Drug and Alcohol Dependence response to KK-21-1460 "Considering rationales for use in defining subgroups for the treatment of stimulant use disorder"

Affiliations

¹ Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States. Electronic address: chanbri@ohsu.edu.
² Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States.

Comment

Brian Chan et al. Drug Alcohol Depend. 2021.

. 2021 Apr 1:221:108571.

doi: 10.1016/j.drugalcdep.2021.108571. Epub 2021 Feb 4.

¹ Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States. Electronic address: chanbri@ohsu.edu.
² Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States.

No abstract available

Comment on

A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.
Chan B, Freeman M, Ayers C, Korthuis PT, Paynter R, Kondo K, Kansagara D. Chan B, et al. Drug Alcohol Depend. 2020 Nov 1;216:108193. doi: 10.1016/j.drugalcdep.2020.108193. Epub 2020 Aug 1. Drug Alcohol Depend. 2020. PMID: 32861136 Free PMC article.
Considering rationales for use in defining subgroups for the treatment of stimulant use disorder.
Brooks O, Bach P, Hayashi K. Brooks O, et al. Drug Alcohol Depend. 2021 Apr 1;221:108572. doi: 10.1016/j.drugalcdep.2021.108572. Epub 2021 Feb 9. Drug Alcohol Depend. 2021. PMID: 33593678 Free PMC article. No abstract available.